Rhythm Pharmaceuticals Announces Topline Results from Phase 3 EMANATE Trial

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/12/2026

1. ORCL
2. ADBE
3. RH
4. SPY
5. CPRT
6. ACVA
7. SEDG
8. SPCX
9. TLT
10. PMTS

Go back to Rhythm Pharmaceuticals Announces Topline Results from Phase 3 EMANATE Trial
(NASDAQ: RYTM) Delayed: 104.71 +2.51 (2.46%)
Previous Close $102.20    52 Week High $ 
Open $102.96    52 Week Low $ 
Day High $106.57    P/E N/A 
Day Low $102.25    EPS $ 
Volume 573,723